Pharmacology

Action Mechanism of Action Reference
VACCINE ANTIGEN Tetanus toxoid vaccine antigen

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Infections 3 D007239 ClinicalTrials
Dengue 3 D003715 ClinicalTrials
Pneumonia 3 D011014 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Severe Dengue 3 D019595 ClinicalTrials
Multiple Sclerosis 3 D009103 ClinicalTrials
Meningococcal Infections 3 D008589 ClinicalTrials
Meningitis, Meningococcal 3 D008585 ClinicalTrials
Oligodendroglioma 2 D009837 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Astrocytoma 2 D001254 ClinicalTrials
Peritoneal Neoplasms 2 D010534 ClinicalTrials
Fallopian Tube Neoplasms 2 D005185 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Paraganglioma 2 D010235 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Alzheimer Disease 1 D000544 ClinicalTrials
Typhoid Fever 1 D014435 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108875
FDA SRS K3W1N8YP13